FOLFIRI® and Bevacizumab in first-line treatment for colorectal cancer patients: safety, efficacy and genetic polymorphisms

Safety and efficacy of FOLFOXIRI with or without targeted agents as first-line treatment of selected elderly metastatic colorectal cancer patients: a pooled analysis of GONO studies

Annals of Oncology ◽

10.1093/annonc/mdw335.14 ◽

2016 ◽

Vol 27 ◽

pp. iv43

Author(s):

D. Rossini ◽

M. Casagrande ◽

R. Moretto ◽

F. Loupakis ◽

C. Cremolini ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Pooled Analysis ◽

Line Treatment ◽

Targeted Agents ◽

First Line ◽

Safety And Efficacy ◽

Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study

British Journal of Cancer ◽

10.1038/sj.bjc.6603493 ◽

2007 ◽

Vol 96 (3) ◽

pp. 439-444 ◽

Cited By ~ 21

Author(s):

E Bajetta ◽

◽

M Di Bartolomeo ◽

R Buzzoni ◽

L Mariani ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

P9 Comparison of cetuximab and bevacizumab as first-line treatment in KRAS wild type advanced colorectal cancer patients: a retrospective analysis

European Journal of Cancer ◽

10.1016/s0959-8049(14)70040-1 ◽

2014 ◽

Vol 50 ◽

pp. S12

Author(s):

Q. Zhang ◽

R. Leung ◽

H. Wong ◽

J. Chiu ◽

K.W. Chu ◽

...

Keyword(s):

Colorectal Cancer ◽

Retrospective Analysis ◽

Cancer Patients ◽

Advanced Colorectal Cancer ◽

Line Treatment ◽

Wild Type ◽

First Line ◽

438P First line treatment patterns in BRAFV600E-mutant metastatic colorectal cancer patients (mCRC): The CAPSTAN European retrospective study

Annals of Oncology ◽

10.1016/j.annonc.2021.08.959 ◽

2021 ◽

Vol 32 ◽

pp. S553

Author(s):

B. Asselain ◽

E. Martinelli ◽

C. Cremolini ◽

T. Mazard ◽

J. Vidal ◽

...

Keyword(s):

Colorectal Cancer ◽

Retrospective Study ◽

Cancer Patients ◽

Treatment Patterns ◽

Line Treatment ◽

First Line ◽

Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab

International Journal of Colorectal Disease ◽

10.1007/s00384-010-1108-1 ◽

2010 ◽

Vol 26 (2) ◽

pp. 143-151 ◽

Cited By ~ 58

Author(s):

Vincenzo Formica ◽

Raffaele Palmirotta ◽

Girolamo Del Monte ◽

Annalisa Savonarola ◽

Giorgia Ludovici ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Predictive Value ◽

Gene Polymorphisms ◽

Line Treatment ◽

Vegf Gene ◽

First Line ◽

UGT1A1 genotyping for irinotecan-based chemotherapy in the first-line treatment for metastatic colorectal cancer patients with hyperbilirubinemia: Report of cases

Biomarkers and Genomic Medicine ◽

10.1016/j.bgm.2013.08.005 ◽

2013 ◽

Vol 5 (3) ◽

pp. 132-133

Author(s):

Yung-Sung Yeh ◽

Ming-Xia Wu ◽

Meng-Lin Huang ◽

Se-Fen Chang ◽

Chin-Fan Chen ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Line Treatment ◽

First Line ◽

627 POSTER UFT/LV combined with oxaliplatin (TEGAFOX) or with irinotecan (TEGAFIRI) as first-line treatment for metastatic colorectal cancer patients (pts). results of a randomized phase II I.T.M.O. study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)80923-1 ◽

2005 ◽

Vol 3 (2) ◽

pp. 177

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients

Oncotarget ◽

10.18632/oncotarget.14810 ◽

2017 ◽

Vol 8 (10) ◽

pp. 16887-16898 ◽

Cited By ~ 12

Author(s):

Mariantonietta Di Salvatore ◽

Filippo Pietrantonio ◽

Armando Orlandi ◽

Marzia Del Re ◽

Rosa Berenato ◽

...

Keyword(s):

Colorectal Cancer ◽

Treatment Outcomes ◽

Cancer Patients ◽

Line Treatment ◽

First Line ◽

Enos Polymorphisms ◽

Comparison of Cetuximab and Bevacizumab as First-Line Treatment in KRAS Wild Type Advanced Colorectal Cancer Patients: A Retrospective Analysis

Annals of Oncology ◽

10.1093/annonc/mdu165.199 ◽

2014 ◽

Vol 25 ◽

pp. ii76

Author(s):

Zhang Qian ◽

Yau Thomas ◽

Leung Roland ◽

Wong Hilda ◽

Chiu Joanne ◽

...

Keyword(s):

Colorectal Cancer ◽

Retrospective Analysis ◽

Cancer Patients ◽

Advanced Colorectal Cancer ◽

Line Treatment ◽

Wild Type ◽

First Line ◽

The best strategy for RAS wild-type metastatic colorectal cancer patients in first-line treatment: A classic and Bayesian meta-analysis

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2018.03.003 ◽

2018 ◽

Vol 125 ◽

pp. 69-77 ◽

Cited By ~ 6

Author(s):

Domenico Ciliberto ◽

Nicoletta Staropoli ◽

Francesca Caglioti ◽

Silvia Chiellino ◽

Antonella Ierardi ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Meta Analysis ◽

Line Treatment ◽

Wild Type ◽

First Line ◽